AAAAAA

   
Results: 1-25 | 26-50 | 51-75
Results: 1-25/75
HIV-1 REVERSE-TRANSCRIPTASE CODON-215 MUTATION IN PLASMA RNA - IMMUNOLOGICAL AND VIROLOGICAL RESPONSES TO ZIDOVUDINE
Authors: REY D HUGHES M PI JT WINTERS M MERIGAN TC KATZENSTEIN DA
Citation: D. Rey et al., HIV-1 REVERSE-TRANSCRIPTASE CODON-215 MUTATION IN PLASMA RNA - IMMUNOLOGICAL AND VIROLOGICAL RESPONSES TO ZIDOVUDINE, Journal of acquired immune deficiency syndromes and human retrovirology, 17(3), 1998, pp. 203-208
GENERATION OF PRIMARY PEPTIDE-SPECIFIC CD8(-LYMPHOCYTES IN-VITRO USING ALLOGENEIC DENDRITIC CELLS() CYTOTOXIC T)
Authors: PESHWA MV BENIKE C DUPUIS M KUNDU SK ENGLEMAN EG MERIGAN TC VANSCHOOTEN WCA
Citation: Mv. Peshwa et al., GENERATION OF PRIMARY PEPTIDE-SPECIFIC CD8(-LYMPHOCYTES IN-VITRO USING ALLOGENEIC DENDRITIC CELLS() CYTOTOXIC T), Cell transplantation, 7(1), 1998, pp. 1-9
A PILOT CLINICAL-TRIAL OF HIV ANTIGEN-PULSED ALLOGENEIC AND AUTOLOGOUS DENDRITIC CELL THERAPY IN HIV-INFECTED PATIENTS
Authors: KUNDU SK ENGLEMAN E BENIKE C SHAPERO MH DUPUIS M VANSCHOOTEN WCA EIBL M MERIGAN TC
Citation: Sk. Kundu et al., A PILOT CLINICAL-TRIAL OF HIV ANTIGEN-PULSED ALLOGENEIC AND AUTOLOGOUS DENDRITIC CELL THERAPY IN HIV-INFECTED PATIENTS, AIDS research and human retroviruses, 14(7), 1998, pp. 551-560
CHANGES IN CD4(-CELL SUBSETS IN RESPONSE TO HIGHLY-ACTIVE ANTIRETROVIRAL THERAPY IN HIV TYPE 1-INFECTED PATIENTS WITH PRIOR PROTEASE INHIBITOR EXPERIENCE() AND CD8(+) T)
Authors: GRAY CM SCHAPIRO JM WINTERS MA MERIGAN TC
Citation: Cm. Gray et al., CHANGES IN CD4(-CELL SUBSETS IN RESPONSE TO HIGHLY-ACTIVE ANTIRETROVIRAL THERAPY IN HIV TYPE 1-INFECTED PATIENTS WITH PRIOR PROTEASE INHIBITOR EXPERIENCE() AND CD8(+) T), AIDS research and human retroviruses, 14(7), 1998, pp. 561-569
GEOGRAPHIC AND DEMOGRAPHIC DIFFERENCES IN THE FREQUENCY OF HUMAN CYTOMEGALOVIRUS GB GENOTYPES 1-4 IN IMMUNOCOMPROMISED PATIENTS
Authors: ZIPETO D HONG C GERNA G ZAVATTONI M KATZENSTEIN D MERIGAN TC RASMUSSEN L
Citation: D. Zipeto et al., GEOGRAPHIC AND DEMOGRAPHIC DIFFERENCES IN THE FREQUENCY OF HUMAN CYTOMEGALOVIRUS GB GENOTYPES 1-4 IN IMMUNOCOMPROMISED PATIENTS, AIDS research and human retroviruses, 14(6), 1998, pp. 533-536
HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE GENOTYPES AND IN-VITRO PROTEASE INHIBITOR SUSCEPTIBILITIES OF ISOLATES FROM INDIVIDUALS WHO WERE SWITCHED TO OTHER PROTEASE INHIBITORS AFTER LONG-TERM SAQUINAVIR TREATMENT
Authors: WINTERS MA SCHAPIRO JM LAWRENCE J MERIGAN TC
Citation: Ma. Winters et al., HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE GENOTYPES AND IN-VITRO PROTEASE INHIBITOR SUSCEPTIBILITIES OF ISOLATES FROM INDIVIDUALS WHO WERE SWITCHED TO OTHER PROTEASE INHIBITORS AFTER LONG-TERM SAQUINAVIR TREATMENT, Journal of virology, 72(6), 1998, pp. 5303-5306
LYMPH-NODE HUMAN-IMMUNODEFICIENCY-VIRUS RNA LEVELS AND RESISTANCE MUTATIONS IN PATIENTS RECEIVING HIGH-DOSE SAQUINAVIR
Authors: SCHAPIRO JM WINTERS MA VIERRA M CRAWFORD S MERIGAN TC
Citation: Jm. Schapiro et al., LYMPH-NODE HUMAN-IMMUNODEFICIENCY-VIRUS RNA LEVELS AND RESISTANCE MUTATIONS IN PATIENTS RECEIVING HIGH-DOSE SAQUINAVIR, The Journal of infectious diseases, 177(2), 1998, pp. 477-480
A 6-BASEPAIR INSERT IN THE REVERSE-TRANSCRIPTASE GENE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 CONFERS RESISTANCE TO MULTIPLE NUCLEOSIDE INHIBITORS
Authors: WINTERS MA COOLLEY KL GIRARD YA LEVEE DJ HAMDAN H SHAFER RW KATZENSTEIN DA MERIGAN TC
Citation: Ma. Winters et al., A 6-BASEPAIR INSERT IN THE REVERSE-TRANSCRIPTASE GENE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 CONFERS RESISTANCE TO MULTIPLE NUCLEOSIDE INHIBITORS, The Journal of clinical investigation, 102(10), 1998, pp. 1769-1775
MULTIPLE CONCURRENT REVERSE-TRANSCRIPTASE AND PROTEASE MUTATIONS AND MULTIDRUG-RESISTANCE OF HIV-1 ISOLATES FROM HEAVILY TREATED PATIENTS
Authors: SHAFER RW WINTERS MA PALMER S MERIGAN TC
Citation: Rw. Shafer et al., MULTIPLE CONCURRENT REVERSE-TRANSCRIPTASE AND PROTEASE MUTATIONS AND MULTIDRUG-RESISTANCE OF HIV-1 ISOLATES FROM HEAVILY TREATED PATIENTS, Annals of internal medicine, 128(11), 1998, pp. 906-911
EFFECT OF THERAPEUTIC IMMUNIZATION WITH RECOMBINANT GP160 HIV-1 VACCINE ON HIV-1 PROVIRAL DNA AND PLASMA RNA - RELATIONSHIP TO CELLULAR IMMUNE-RESPONSES
Authors: KUNDU SK KATZENSTEIN D VALENTINE FT SPINO C EFRON B MERIGAN TC
Citation: Sk. Kundu et al., EFFECT OF THERAPEUTIC IMMUNIZATION WITH RECOMBINANT GP160 HIV-1 VACCINE ON HIV-1 PROVIRAL DNA AND PLASMA RNA - RELATIONSHIP TO CELLULAR IMMUNE-RESPONSES, Journal of acquired immune deficiency syndromes and human retrovirology, 15(4), 1997, pp. 269-274
ALLOGENEIC DENDRITIC CELL INDUCTION OF HIV-SPECIFIC CYTOTOXIC T-LYMPHOCYTE RESPONSES FROM T-CELLS OF HIV TYPE 1-INFECTED AND UNINFECTED INDIVIDUALS
Authors: DUPUIS M PESHWA MV BENIKE C KUNDU SK ENGLEMAN EG VANSCHOOTEN WCA MERIGAN TC
Citation: M. Dupuis et al., ALLOGENEIC DENDRITIC CELL INDUCTION OF HIV-SPECIFIC CYTOTOXIC T-LYMPHOCYTE RESPONSES FROM T-CELLS OF HIV TYPE 1-INFECTED AND UNINFECTED INDIVIDUALS, AIDS research and human retroviruses, 13(1), 1997, pp. 33-39
COMPARISON OF QIAAMP HCV KIT SPIN COLUMNS, SILICA BEADS, AND PHENOL-CHLOROFORM FOR RECOVERING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA FROM PLASMA
Authors: SHAFER RW LEVEE DJ WINTERS MA RICHMOND KL HUANG D MERIGAN TC
Citation: Rw. Shafer et al., COMPARISON OF QIAAMP HCV KIT SPIN COLUMNS, SILICA BEADS, AND PHENOL-CHLOROFORM FOR RECOVERING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA FROM PLASMA, Journal of clinical microbiology, 35(2), 1997, pp. 520-522
A PHASE-I CLINICAL-TRIAL OF HIV ANTIGEN-PULSED ALLOGENEIC AND AUTOLOGOUS DENDRITIC CELL (DC) THERAPY IN HIV-INFECTED PATIENTS
Authors: KUNDU SK ENGLEMAN E BENIKE C SCHAPERO MH DUPUIS M VANSCHOOTEN WCA EIBL M MERIGAN TC
Citation: Sk. Kundu et al., A PHASE-I CLINICAL-TRIAL OF HIV ANTIGEN-PULSED ALLOGENEIC AND AUTOLOGOUS DENDRITIC CELL (DC) THERAPY IN HIV-INFECTED PATIENTS, Journal of allergy and clinical immunology, 99(1), 1997, pp. 435-435
HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE GENOTYPE AND DRUG SUSCEPTIBILITY CHANGES IN INFECTED INDIVIDUALS RECEIVING DIDEOXYINOSINE MONOTHERAPY FOR 1 TO 2 YEARS
Authors: WINTERS MA SHAFER RW JELLINGER RA MAMTORA G GINGERAS T MERIGAN TC
Citation: Ma. Winters et al., HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE GENOTYPE AND DRUG SUSCEPTIBILITY CHANGES IN INFECTED INDIVIDUALS RECEIVING DIDEOXYINOSINE MONOTHERAPY FOR 1 TO 2 YEARS, Antimicrobial agents and chemotherapy, 41(4), 1997, pp. 757-762
SEQUENCE AND DRUG SUSCEPTIBILITY OF SUBTYPE-C REVERSE-TRANSCRIPTASE FROM HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SEROCONVERTERS IN ZIMBABWE
Authors: SHAFER RW EISEN JA MERIGAN TC KATZENSTEIN DA
Citation: Rw. Shafer et al., SEQUENCE AND DRUG SUSCEPTIBILITY OF SUBTYPE-C REVERSE-TRANSCRIPTASE FROM HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SEROCONVERTERS IN ZIMBABWE, Journal of virology, 71(7), 1997, pp. 5441-5448
RISK FOR RETINITIS IN PATIENTS WITH AIDS CAN BE ASSESSED BY QUANTITATION OF THRESHOLD LEVELS OF CYTOMEGALOVIRUS DNA BURDEN IN BLOOD
Authors: RASMUSSEN L ZIPETO D WOLITZ RA DOWLING A EFRON B MERIGAN TC
Citation: L. Rasmussen et al., RISK FOR RETINITIS IN PATIENTS WITH AIDS CAN BE ASSESSED BY QUANTITATION OF THRESHOLD LEVELS OF CYTOMEGALOVIRUS DNA BURDEN IN BLOOD, The Journal of infectious diseases, 176(5), 1997, pp. 1146-1155
A NOVEL-APPROACH TO ASSESSING THE DRUG SUSCEPTIBILITY AND REPLICATIONOF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES
Authors: JELLINGER RM SHAFER RW MERIGAN TC
Citation: Rm. Jellinger et al., A NOVEL-APPROACH TO ASSESSING THE DRUG SUSCEPTIBILITY AND REPLICATIONOF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES, The Journal of infectious diseases, 175(3), 1997, pp. 561-566
CYTOMEGALOVIRUS GB GENOTYPE DISTRIBUTION DIFFERS IN HUMAN-IMMUNODEFICIENCY-VIRUS - INFECTED PATIENTS AND IMMUNOCOMPROMISED ALLOGRAFT RECIPIENTS
Authors: RASMUSSEN L HONG C ZIPETO D MORRIS S SHERMAN D CHOU SW MINER R DREW WL WOLITZ R DOWLING A WARFORD A MERIGAN TC
Citation: L. Rasmussen et al., CYTOMEGALOVIRUS GB GENOTYPE DISTRIBUTION DIFFERS IN HUMAN-IMMUNODEFICIENCY-VIRUS - INFECTED PATIENTS AND IMMUNOCOMPROMISED ALLOGRAFT RECIPIENTS, The Journal of infectious diseases, 175(1), 1997, pp. 179-184
HETEROGENEITY OF CYTOKINE FUNCTIONS IN HIV-INFECTION
Authors: KUNDU SK MERIGAN TC
Citation: Sk. Kundu et Tc. Merigan, HETEROGENEITY OF CYTOKINE FUNCTIONS IN HIV-INFECTION, Immunology, 91(2), 1997, pp. 234-238
EXTENSIVE POLYMORPHISMS OBSERVED IN HIV-1 CLADE-B PROTEASE GENE USINGHIGH-DENSITY OLIGONUCLEOTIDE ARRAYS
Authors: KOZAL MJ SHAH N SHEN NP YANG R FUCINI R MERIGAN TC RICHMAN DD MORRIS D HUBBELL ER CHEE M GINGERAS TR
Citation: Mj. Kozal et al., EXTENSIVE POLYMORPHISMS OBSERVED IN HIV-1 CLADE-B PROTEASE GENE USINGHIGH-DENSITY OLIGONUCLEOTIDE ARRAYS, Nature medicine, 2(7), 1996, pp. 753-759
COMBINATION THERAPY FOR HIV-INFECTION - NEW PERSPECTIVES - SATELLITE SYMPOSIUM TO THE 19TH INTERNATIONAL-CONGRESS ON CHEMOTHERAPY 18 JULY 1935 MONTREAL, CANADA - INTRODUCTION
Authors: MERIGAN TC WAINBERG MA
Citation: Tc. Merigan et Ma. Wainberg, COMBINATION THERAPY FOR HIV-INFECTION - NEW PERSPECTIVES - SATELLITE SYMPOSIUM TO THE 19TH INTERNATIONAL-CONGRESS ON CHEMOTHERAPY 18 JULY 1935 MONTREAL, CANADA - INTRODUCTION, AIDS, 10, 1996, pp. 1-1
TRANSLATING CLINICAL-TRIALS TO CLINICAL-PRACTICE - SATELLITE SYMPOSIUM TO THE 2ND INTERNATIONAL-CONGRESS ON DRUG-THERAPY IN HIV-INFECTION -INTRODUCTION
Authors: PINCHING AJ MERIGAN TC
Citation: Aj. Pinching et Tc. Merigan, TRANSLATING CLINICAL-TRIALS TO CLINICAL-PRACTICE - SATELLITE SYMPOSIUM TO THE 2ND INTERNATIONAL-CONGRESS ON DRUG-THERAPY IN HIV-INFECTION -INTRODUCTION, AIDS, 10, 1996, pp. 1-1
THE PROGNOSTIC-SIGNIFICANCE OF SERUM VIRAL LOAD, CODON-215 REVERSE-TRANSCRIPTASE MUTATION AND CD4-CELLS ON PROGRESSION OF HIV DISEASE IN A DOUBLE-BLIND-STUDY OF THYMOPENTIN( T)
Authors: MERIGAN TC HIRSCH RL FISHER AC MEYERSON LA GOLDSTEIN G WINTERS MA
Citation: Tc. Merigan et al., THE PROGNOSTIC-SIGNIFICANCE OF SERUM VIRAL LOAD, CODON-215 REVERSE-TRANSCRIPTASE MUTATION AND CD4-CELLS ON PROGRESSION OF HIV DISEASE IN A DOUBLE-BLIND-STUDY OF THYMOPENTIN( T), AIDS, 10(2), 1996, pp. 159-165
AN ASSESSMENT OF PHENOTYPIC AND GENOTYPIC CORESISTANCE TO INHIBITORS OF HIV PROTEINASE FOLLOWING THERAPY WITH HIGH-DOSE SAQUINAVIR
Authors: WHITTAKER L SCHAPIRO JM CRAIG JC WINTERS MA TOMLINSON PW SHELDON JG MOFFATT AR JACOBSEN H DUNCAN IB GILBERT S CRAWFORD S MERIGAN TC
Citation: L. Whittaker et al., AN ASSESSMENT OF PHENOTYPIC AND GENOTYPIC CORESISTANCE TO INHIBITORS OF HIV PROTEINASE FOLLOWING THERAPY WITH HIGH-DOSE SAQUINAVIR, AIDS, 10, 1996, pp. 17-17
RESEARCH IN THE POST LICENSING SITUATION
Authors: MERIGAN TC
Citation: Tc. Merigan, RESEARCH IN THE POST LICENSING SITUATION, AIDS, 10, 1996, pp. 34-34
Risultati: 1-25 | 26-50 | 51-75